Rentschler Company News

April 15, 2014

Guest lectures at colleges and universities

Rentschler employees promote the education of the next generation.  read more

March 21, 2014

Presentations at major conferences in the area of development of protein therapeutics

In recent weeks two representatives of Rentschler participated at major international conferences and presented important experiences and results from technology development and production. read more

March 14, 2014

Rentschler announces 3. Laupheimer Zelltage

`Processes for Virus-based Biologics´ is the focus of this year´s 3. Laupheimer Zelltage, which will be held from June 2-3. read more

March 10, 2014

Article in March Issue of Transkript Magazine

Platform Technology and Individual Process, time-saving and cost-effective tachniques are required.

August 1, 2013

Rentschler produces Apeiron's monoclonal antibody APN311 for late stage clinical development and market

APEIRON Biologics AG (Apeiron), a biotech company focused on immunologic and biologic therapies against cancer, and RENTSCHLER Biotechnologie GmbH (Rentschler), a full service biopharmaceutical contract manufacturer, jointly announce a partnership agreement to manufacture GMP material for various advanced clinical studies and later on for market supply of Apeiron’s lead program APN311.

 

 read more

March 7, 2013

Rentschler Appoints New Chief Business Officer

Seasoned industry expert Frank Ternes joins executive Management Board read more

November 7, 2012

Necessary Expansion of the Management Board at Rentschler Biotechnologie GmbH

The family-owned business based in Laupheim has expanded its management board. As a contract manufacturing organization, Rentschler Biotechnologie GmbH performs research on, develops, and produces biologicals for its international clientele. read more

July 25, 2012

2. Laupheimer Zelltage Attracts Top Scientists to Discuss Recent Advances in Biomanufacturing

Rentschler has seen participation at this conference nearly triple since inaugural event in 2010 read more

July 17, 2012

New Campaign for Rentschler's "Facility of the Year"

Rentschler, one of the most qualified partners for the development and production of biopharmaceuticals worldwide, has undergone significant expansion in the past years and has transformed itself into a leading contract manufacturer of clinical trial material and for market supply of drug products ranging from low-dose cytokines to higher-dose antibodies and biosimilars read more

January 30, 2012

Rentschler Announces 2. Laupheimer Zelltage on Industrial Cell Culture Technology

Rentschler Biotechnologie GmbH is pleased to announce the second Laupheimer Zelltage , a biennial industrial cell culture technology conference to be held on June 11-12, 2012 at Laupheim's historical castle, Schloss Großlaupheim. read more

Displaying news 1 to 10 out of 11

Rentschler Biotechnologie GmbH
Erwin-Rentschler-Str. 21
88471 Laupheim

Telefon: +49 - 7392 701-0
Telefax: +49 - 7392 701-300
E-Mail: info@rentschler.de

Web address of this page http://rentschler.de/en/information/news/